T Cell Tech
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $40M
Investors
- 4
About T Cell Tech
Founded in 2017 in Fuzhou, China, T Cell Tech specializes in biotechnology with a focus on therapeutic development., Ltd.T Cell Tech provides innovative therapeutic solutions primarily in the field of immunotherapy. Their offerings include a comprehensive suite of products designed to enhance treatment efficacy and patient outcomes in various medical applications.The company generates revenue through a structured model that includes collaborations with research institutions and pharmaceutical companies. Revenue streams are bolstered by strategic partnerships aimed at advancing clinical trials and market applications of their therapeutic products. The company aims to expand its global presence, particularly in key markets across North America and Europe, and enhance its research and development capabilities for other pipeline projects.
Who invested in T Cell Tech
4 investors across 1 round
See all investors in T Cell Tech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 15, 2025
Amount
$40M
Investors
Questions about T Cell Tech
Who invested in T Cell Tech?
T Cell Tech has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has T Cell Tech raised?
T Cell Tech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did T Cell Tech last raise money?
T Cell Tech's most recent round on record is a Series B, in Jul 2025.
What does T Cell Tech do?
Founded in 2017 in Fuzhou, China, T Cell Tech specializes in biotechnology with a focus on therapeutic development.
Where is T Cell Tech headquartered?
T Cell Tech is headquartered in Fuzhou, China.
Which VCs invest in companies like T Cell Tech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at T Cell Tech's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like T Cell Tech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.